Skip to main content

Table 3 Global and regional myocardial strain parameters for HHD and healthy control groups

From: Sensitive marker for evaluation of hypertensive heart disease: extracellular volume and myocardial strain

 

HHD(n = 62)

Controls

(n = 26)

P value

EF < 30%

(n = 22)

30%EF < 50%

(n = 18)

EF50

(n = 22)

RS

 Global

8.2 ± 2.9

13.8 ± 4.3

29.1 ± 6.0

35.6 ± 7.5

< 0.01a b c e d f

 Base

9.6 (7.3)

16.9 (10.4)(14.5817.39)

30.4 (17.0)

43.2 (17.0)

< 0.05a b e f

 Middle

6.6 (4.0)

10.3 (5.2)

25.4 (8.9)

31.9 (14.2)

< 0.01a b e f

 Apex

8.6 ± 5.9

13.7 ± 3.9

31.3 ± 11.1

36.2 ± 10.9

< 0.01a b e f

CS

 Global

−7.1 (3.2)

−10.1 (3.2)

−19.6 (4.8)

−20.5 (4.1)

< 0.01a b e f

 Base

−6.5 (2.5)

−10.1 (3.2)

−17.5 (5.8)

−18.9 (3.8)

< 0.01a b e f

 Middle

−6.2 (3.0)

−10.8 (3.3)

−20.2 (3.9)

−20.7 (4.2)

< 0.01a b e f

 Apex

−9.2 (4.9)

−12.6 (5.1)

−22.5 (5.2)(24.74)

−22.8 (5.3)(23.29)

< 0.01a b e f

LS

 Global

−4.0 (2.9)

−6.5 (2.4)

−12.1 (3.8)

−14.9 (3.6)

< 0.05 a b e f

 Base

−2.7 (7.3)

−4.7 (4.5)

−10.4 (6.2)

−12.6 (4.8)

< 0.05 a b e f

 Middle

−3.7 (3.2)

−6.5 (3.6)

−12.1 (6.0)

−14.2 (4.7)

< 0.05 a b e f

 Apex

−5.4 (2.9)

−10.0 (3.0)

−14.9 (3.4)(35.55)

−17.9 (4.1)

< 0.05 a b e f

  1. Abbreviations: a EF < 30% compared with Controls; b 30%EF < 50% compared with Controls; c EF50 compared with Controls; d EF < 30% compared with 30%EF < 50%; e EF < 30% compared with EF50; f 30%EF < 50% compared with EF50